Literature DB >> 7733854

Individual variability in responses to nicotine.

K A Perkins1.   

Abstract

Individual variability in acute responses to nicotine, which may be defined as variable magnitude of effects following controlled dosing, is generally attributed to stable characteristics of tobacco users such as genetic/constitutional factors or to chronic behavioral factors (e.g., long-term use of other drugs). Often overlooked, however, is that such variability may also be due to the transient influence of the situational factors in which people consume nicotine, such as acute stress or physical activity. Results of selected studies from the author's laboratory provide examples of each of these sources of variability in nicotine responding on subjective, behavioral, and physiological measures. All studies used a nasal spray method of nicotine dosing or controlled smoking (paced puffing) to control acute nicotine exposure, an essential methodological feature of any research on individual differences in acute responses to nicotine. As an example of genetic/constitutional factors, gender differences in nicotine responding have begun to receive some attention, with few differences emerging. However, females may be more responsive than males to nonnicotine stimuli associated with smoking (e.g., sight and taste of smoke). In terms of chronic behavioral factors, long-term use of nicotine produces attenuation of most subjective and some behavioral effects of nicotine, reflecting chronic tolerance, and the possibility that chronic use of other drugs may alter responses to nicotine (i.e., cross-tolerance or cross-sensitization) deserves greater study. Of particular emphasis in this review is the modulating influence of acute situational factors on nicotine responding. Human studies have shown that magnitude of nicotine's subjective effects may depend on the predrug subjective state, level of physical activity vs. rest, and concurrent acute intake of other drugs, among other situational factors. Proper consideration of these situational factors may reveal the greatest source of individual variability in responding to nicotine and clarify the impact of more stable genetic/constitutional or chronic environmental factors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7733854     DOI: 10.1007/bf02196922

Source DB:  PubMed          Journal:  Behav Genet        ISSN: 0001-8244            Impact factor:   2.805


  68 in total

1.  Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention.

Authors:  J D Killen; S P Fortmann; B Newman; A Varady
Journal:  J Consult Clin Psychol       Date:  1990-02

2.  Chronic and acute tolerance to the heart rate effects of nicotine.

Authors:  K A Perkins; L H Epstein; R L Stiller; B L Marks; R G Jacob
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 3.  Addictive behaviors: etiology and treatment.

Authors:  G A Marlatt; J S Baer; D M Donovan; D R Kivlahan
Journal:  Annu Rev Psychol       Date:  1988       Impact factor: 24.137

Review 4.  Dose-related actions of nicotine on behavior and physiology: review and implications for replacement therapy for nicotine dependence.

Authors:  J E Henningfield; P P Woodson
Journal:  J Subst Abuse       Date:  1989

5.  Chronic and acute tolerance to subjective, behavioral and cardiovascular effects of nicotine in humans.

Authors:  K A Perkins; J E Grobe; C Fonte; J Goettler; A R Caggiula; W A Reynolds; R L Stiller; A Scierka; R G Jacob
Journal:  J Pharmacol Exp Ther       Date:  1994-08       Impact factor: 4.030

6.  Acute effects of tobacco smoking on hunger and eating in male and female smokers.

Authors:  K A Perkins; J E Sexton; A DiMarco; C Fonte
Journal:  Appetite       Date:  1994-04       Impact factor: 3.868

7.  Coffee drinking and cigarette smoking: I. Coffee, caffeine and cigarette smoking behavior.

Authors:  W R Marshall; L H Epstein; S B Green
Journal:  Addict Behav       Date:  1980       Impact factor: 3.913

8.  Nicotine dependence in cigarette smoking: an empirically-based, multivariate model.

Authors:  O F Pomerleau; J B Fertig; S O Shanahan
Journal:  Pharmacol Biochem Behav       Date:  1983-08       Impact factor: 3.533

9.  Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers.

Authors:  N L Benowitz; P Jacob
Journal:  Clin Pharmacol Ther       Date:  1993-03       Impact factor: 6.875

10.  How a cigarette is smoked determines blood nicotine levels.

Authors:  R I Herning; R T Jones; N L Benowitz; A H Mines
Journal:  Clin Pharmacol Ther       Date:  1983-01       Impact factor: 6.875

View more
  22 in total

1.  Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender.

Authors:  Sarah E Evans; Melissa Blank; Cynthia Sams; Michael F Weaver; Thomas Eissenberg
Journal:  Exp Clin Psychopharmacol       Date:  2006-05       Impact factor: 3.157

2.  Paced smoking in the laboratory and in the natural smoking setting: differential situation-specific effects in light and heavy smokers.

Authors:  P E Schupp; R F Mucha; P Pauli
Journal:  Psychopharmacology (Berl)       Date:  1996-10       Impact factor: 4.530

3.  Modeling naturalistic craving, withdrawal, and affect during early nicotine abstinence: A pilot ecological momentary assessment study.

Authors:  Spencer Bujarski; Daniel J O Roche; Erin S Sheets; Jennifer L Krull; Iris Guzman; Lara A Ray
Journal:  Exp Clin Psychopharmacol       Date:  2015-04       Impact factor: 3.157

4.  Dopamine receptor blockade modulates the rewarding and aversive properties of nicotine via dissociable neuronal activity patterns in the nucleus accumbens.

Authors:  Ninglei Sun; Steven R Laviolette
Journal:  Neuropsychopharmacology       Date:  2014-06-04       Impact factor: 7.853

5.  Subjective effects of transdermal nicotine among nonsmokers.

Authors:  Rebecca L Ashare; Joseph S Baschnagel; Larry W Hawk
Journal:  Exp Clin Psychopharmacol       Date:  2010-04       Impact factor: 3.157

6.  Genetic, environmental, and situational factors mediating the effects of nicotine--an introduction.

Authors:  D H Overstreet; L Karan; J A Rosecrans
Journal:  Behav Genet       Date:  1995-03       Impact factor: 2.805

7.  Intravenous Nicotine Self-Administration in Smokers: Dose-Response Function and Sex Differences.

Authors:  Kevin P Jensen; Elise E DeVito; Gerald Valentine; Ralitza Gueorguieva; Mehmet Sofuoglu
Journal:  Neuropsychopharmacology       Date:  2015-12-31       Impact factor: 7.853

8.  Nicotine discrimination in male and female smokers.

Authors:  K A Perkins; A DiMarco; J E Grobe; A Scierka; R L Stiller
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

Review 9.  Abuse liability assessment of tobacco products including potential reduced exposure products.

Authors:  Lawrence P Carter; Maxine L Stitzer; Jack E Henningfield; Rich J O'Connor; K Michael Cummings; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

10.  Influence of training dose on nicotine discrimination in humans.

Authors:  K A Perkins; D D'Amico; M Sanders; J E Grobe; A Wilson; R L Stiller
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.